Previous Close | 13.75 |
Open | 13.24 |
Bid | 13.46 x 1000 |
Ask | 13.66 x 1100 |
Day's Range | 13.24 - 13.99 |
52 Week Range | 8.05 - 17.25 |
Volume | |
Avg. Volume | 65,590 |
Market Cap | 96.003M |
Beta (5Y Monthly) | 0.99 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.52 |
Earnings Date | Mar 15, 2023 - Mar 20, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 40.17 |
YAVNE, Israel, Feb. 07, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced the closing of its previously announced registered direct offering. The gross proceeds to the Company from the offering were $27.5 million, before deducting placement agent fees and other offering expenses payable by the Company. The Company intends to use the net procee
YAVNE, Israel, Feb. 03, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced that it has entered into a definitive securities purchase agreement for the sale and purchase of1,964,286 shares of the Company’s ordinary shares, par value NIS 0.07, at a purchase price of $14 per share, in a registered direct offering. The Company expec
This month, we saw the MediWound Ltd. ( NASDAQ:MDWD ) up an impressive 39%. But that is little comfort to those holding...